Cimpress R&D Spending Growth & History (CMPR)
Cimpress's r&d spending was $68.6M for fiscal 2026.
View full Cimpress company overviewCimpress annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | $68.6M | $3.6M | +5.54% |
| 2025 | 2025-06-30 | $65.0M | $2.3M | +3.75% |
| 2024 | 2024-06-30 | $62.7M | $3.8M | +6.52% |
| 2023 | 2023-06-30 | $58.8M | $1.8M | +3.20% |
| 2022 | 2022-06-30 | $57.0M | $7.7M | +15.72% |
| 2021 | 2021-06-30 | $49.3M | $53,000 | +0.11% |
| 2020 | 2020-06-30 | $49.2M | $8.2M | +20.07% |
| 2019 | 2019-06-30 | $41.0M | −$475,000 | −1.15% |
| 2018 | 2018-06-30 | $41.5M | — | — |
| 2015 | 2015-06-30 | $30.8M | $4.4M | +16.75% |
| 2014 | 2014-06-30 | $26.4M | $1.7M | +7.02% |
| 2013 | 2013-06-30 | $24.7M | $5.0M | +25.29% |
| 2012 | 2012-06-30 | $19.7M | $8.6M | +77.09% |
| 2011 | 2011-06-30 | $11.1M | $2.6M | +30.90% |
| 2010 | 2010-06-30 | $8.5M | $1.4M | +20.26% |
| 2009 | 2009-06-30 | $7.1M | — | — |
Cimpress quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | $91.7M | $5.5M | +6.38% |
| Q3 2026 | 2026-03-31 | $86.9M | — | — |
| Q2 2026 | 2025-12-31 | $89.1M | — | — |
| Q1 2026 | 2025-09-30 | $84.9M | — | — |
| Q4 2025 | 2025-06-30 | $86.2M | — | — |
Cimpress r&d spending trends
Over the last five fiscal years, Cimpress's r&d spending increased from $49.3M to $68.6M, a change of $19.3M. The latest reported quarter, Q4 2026, shows $91.7M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cimpress source filings ↗